OPTIMIZATION OF INFLUENZA A AND B VIRUSES CULTIVATION CONDITIONS FOR PREPARATION OF TRIVALENT SEASONAL INFLUENZA SPLIT VACCINE

被引:0
|
作者
Akzhunusova, Indira [1 ]
Assanzhanova, Nurika [1 ]
Tabynov, Kaissar [1 ]
Abdrakhmanova, Buryl [2 ]
Sansyzbay, Abilai [1 ]
机构
[1] Res Inst Biol Safety Problems, Gvardeisky 080409, Kazakhstan
[2] Kyrgyz State Univ, Bishkek, Kyrgyzstan
关键词
Influenza A and B viruses; cultivation conditions; chicken embryos; seasonal influenza vaccine;
D O I
10.13040/IJPSR.0975-8232.6(6).2375-81
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
This article presents the results of studies on determination of optimal parameters of recombinant strains A/NYMC X-217 (H3N2) and B/NYMC BX-49 of influenza virus cultivation in chicken embryos. It is found that a maximum virus accumulation is formed under the following cultivation conditions: age of chicken embryos is 9-11 days in case of inoculation of the allantoic cavity, inoculated virus dose - 1,000-10,000 EID50, temperature and time of incubation - (34 +/- 0.5) degrees C and 48 h, respectively. If the cultivation parameters are satisfied, it is possible to obtain a highly active viruscontaining material with infectious and hemagglutinating activity, as well as a content of hemagglutinin not less than 7.0lg EID50/ml, 1: 256 and 7.0 mu g/ml, respectively, that is enough to prepare a trivalent inactive seasonal influenza split vaccine.
引用
收藏
页码:2375 / 2381
页数:7
相关论文
共 50 条
  • [1] Reference viruses for seasonal and pandemic influenza vaccine preparation
    Wood, John M.
    Robertson, James S.
    INFLUENZA AND OTHER RESPIRATORY VIRUSES, 2007, 1 (01) : 5 - 9
  • [2] Seasonal split influenza vaccine induced IgE sensitization against influenza vaccine
    Nakayama, Tetsuo
    Kumagai, Takuji
    Nishimura, Naoko
    Ozaki, Takao
    Okafuji, Teruo
    Suzuki, Eitaro
    Miyata, Akiko
    Okada, Kenji
    Ihara, Toshiaki
    VACCINE, 2015, 33 (45) : 6099 - 6105
  • [3] Seasonal Trivalent Influenza Vaccine for 2009-2010
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2009, 51 (1321): : 73 - 74
  • [4] Seasonal Trivalent Influenza Vaccine for 2010-2011
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2010, 52 (1348): : 77 - 79
  • [5] Cold adaptation improves the growth of seasonal influenza B vaccine viruses
    Kim, Hyunsuh
    Schoofs, Peter
    Anderson, David A.
    Tannock, Gregory A.
    Rockman, Steven P.
    VACCINE, 2014, 32 (21) : 2474 - 2479
  • [6] Immunogenicity of trivalent split influenza vaccine in patients after splenectomy
    Brydak, LB
    Rokicka-Milewska, R
    Laguna, P
    Machala, M
    BRITISH JOURNAL OF HAEMATOLOGY, 1998, 102 (01) : 337 - 337
  • [7] Development of a mucosal vaccine for influenza viruses: preparation for a potential influenza pandemic
    Hasegawa, Hideki
    Ichinohe, Takeshi
    Tamura, Shin-ichi
    Kurata, Takeshi
    EXPERT REVIEW OF VACCINES, 2007, 6 (02) : 193 - 201
  • [8] Rapid safety assessment of a seasonal intradermal trivalent influenza vaccine
    Demeulemeester, Marc
    Lavis, Nathalie
    Balthazar, Yohan
    Lechien, Patrice
    Heijmans, Stephane
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2017, 13 (04) : 889 - 894
  • [9] Recombinant Trivalent Influenza Vaccine (Flublok®): A Review of Its Use in the Prevention of Seasonal Influenza in Adults
    Yang, Lily P. H.
    DRUGS, 2013, 73 (12) : 1357 - 1366
  • [10] Ten Years of Experience with the Trivalent Split-Influenza Vaccine, Fluarix™
    Norbert W. Hehme
    Walter Künzel
    Frank Petschke
    Gisela Türk
    Carmen Raderecht
    Christian van Hoecke
    Roland Sänger
    Clinical Drug Investigation, 2002, 22 : 751 - 769